These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Controlled attenuation parameter: A measure of hepatic steatosis in patients with cystic fibrosis. Bader RM; Jonas MM; Mitchell PD; Wiggins S; Lee CK J Cyst Fibros; 2019 Mar; 18(2):280-285. PubMed ID: 30509601 [TBL] [Abstract][Full Text] [Related]
28. Cystic fibrosis liver disease - from diagnosis to risk factors. Ciucă IM; Pop L; Tămaş L; Tăban S Rom J Morphol Embryol; 2014; 55(1):91-5. PubMed ID: 24715171 [TBL] [Abstract][Full Text] [Related]
29. Liver disease in cystic fibrosis. Rowland M; Bourke B Curr Opin Pulm Med; 2011 Nov; 17(6):461-6. PubMed ID: 21881510 [TBL] [Abstract][Full Text] [Related]
30. Cystic fibrosis related liver disease--another black box in hepatology. Staufer K; Halilbasic E; Trauner M; Kazemi-Shirazi L Int J Mol Sci; 2014 Aug; 15(8):13529-49. PubMed ID: 25093717 [TBL] [Abstract][Full Text] [Related]
31. Review article: epidemiology, pathogenesis and management of liver disease in adults with cystic fibrosis. Scott J; Jones AM; Piper Hanley K; Athwal VS Aliment Pharmacol Ther; 2022 Feb; 55(4):389-400. PubMed ID: 35048397 [TBL] [Abstract][Full Text] [Related]
32. Cystic Fibrosis Liver Disease: Know More. Al Sinani S; Al-Mulaabed S; Al Naamani K; Sultan R Oman Med J; 2019 Nov; 34(6):482-489. PubMed ID: 31745411 [TBL] [Abstract][Full Text] [Related]